General
Preferred name
Desfesoterodine
Synonyms
5-HMT ()
(R)-5-Hydroxymethyl tolterodine ()
PNU-200577 ()
5-HM ()
5-hydroxymethyl tolterodine ()
Spm 7605 ()
5-hydroxymethyltolterodine ()
SPM-7605 ()
5-hydroxymethyl Tolterodine (formate) ()
P&D ID
PD010900
CAS
207679-81-0
380636-49-7
Tags
available
drug candidate
Drug Status
experimental
Drug indication
Urinary incontinence
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Desfesoterodine (PNU-200577) is a potent and selective muscarinic receptor (mAChR) antagonist with a KB and a pA2 of 0.84 nM and 9.14, respectively[1]. Desfesoterodine is a major pharmacologically active metabolite of Tolterodine (PNU-200583; HY-A0024) and Fesoterodine (HY-70053)[2][3]. Desfesoterodine improves cerebral infarction induced detrusor overactivity in rats[4].
PRICE 176
DESCRIPTION 5-hydroxymethyl tolterodine produces a competitive and concentration-dependent inhibition of carbachol-induced contraction of guinea-pig isolated urinary bladder strips. (BOC Sciences Bioactive Compounds)
DESCRIPTION Desfesoterodine (5-HMT) is a new muscarinic receptor antagonist with Kb of 0.84 nM. (TargetMol Bioactive Compound Library)
Compound Sets
8
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
MedChem Express Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
33
Properties
(calculated by RDKit )
Molecular Weight
341.24
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
2
Rotatable Bonds
8
Ring Count
2
Aromatic Ring Count
2
cLogP
4.53
TPSA
43.7
Fraction CSP3
0.45
Chiral centers
1.0
Largest ring
6.0
QED
0.74
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
mAChR
CHRM3
MOA
acetylcholine receptor antagonist
Pathway
Neuroscience
GPCR/G protein
Neuronal Signaling
Source data